BioSpace News Archive

Eisai Inc. presented the latest clinical results on FYCOMPA® (perampanel) CIII, at the 2019 American Academy of Neurology Annual Meeting in Philadelphia, including analyses highlighting the health and economic benefits of FYCOMPA

Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus’ expanded portfolio builds on the organization’s unprecedented mapping and visualization technology platform.

NeuroPace, Inc., a Silicon Valley-based medical technology company, presented long-term clinical results demonstrating that the RNS® System for refractory epilepsy significantly reduces seizure frequency in patients, with one in three people achieving 90% or greater reduction in seizure frequency at nine years.

Drug Topics®, a leading multimedia resource that has served the pharmacy field for over 160 years, is the most-read pharmacy journal among total pharmacists, according the 2019 KANTAR Pharmacy Readership study

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will attend the New Brunswick Hospice and Palliative Care Conference to announce funding for palliative care

The National Council on Compensation Insurance (NCCI) has released an update on marijuana legalization that addresses the top five questions on the minds of workers compensation industry stakeholders.

Health Canada seized a new type of “popper” from Homerama Adult Video, 2524 Eglinton Avenue East, Scarborough, Ontario, that is labelled to contain ethyl chloride.

A new research article published in the May 1 issue of the Journal of the American Academy of Orthopaedic Surgeons found that prolonged opioid use following surgery for traumatic musculoskeletal injuries was related to the quantity of the initial opioid prescribed upon discharge

Magarelli Fertility Makes Enhanced Fertility Services Available to “American Heroes”

The Minister of Indigenous Services, Seamus O’Regan, issued the following statement today